首页 › 股票 › OCUL

OCUL — OCULAR THERAPEUTIX INC

申报持仓市值$2.33B
持有基金数(最新)445
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)271
机构持仓市值$2.05B · 216.58M 股
新建/增持/减仓/清仓34 / 107 / 84 / 46 · 更新于 2026-11-14
前五大/前十大集中度46.3% / 64.0%
机构整体持仓变动 增持 +2.5% (+5.06M 股)
机构持仓市值变动 上升 +16.9%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 271 家机构在其最新 13F 申报中持有 OCUL(OCULAR THERAPEUTIX INC),合计申报市值 $2.05B,对应 216.58M 股。按股数计算较上季度增持 2.5%(+5.06M 股),申报市值环比上升 16.9%。持仓集中度较高:前五大持有人占申报市值的 46.3%,前十大的集中度为 64.0%。

与上一季度相比,34 家新建仓位、107 家加仓、84 家减仓、46 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

OCULAR THERAPEUTIX INC(OCUL)的主要机构持有人包括 Fidelity Management & Research (FMR)、Deep Track Capital, LP、BlackRock Inc,按 13F 申报市值在本页 445 家持有人中排名居前。

OCUL 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 181 121.69M $934.12M +4.7%
Q2 2026 271 216.58M $2.05B +2.5%
Q1 2026 282 213.49M $1.77B +16.8%
Q4 2025 256 191.44M $2.32B +0.0%
Q3 2025 220 185.81M $2.17B +20.3%
Q2 2025 188 152.28M $1.41B +15.6%
Q1 2025 192 133.44M $976.57M -0.6%
Q4 2024 181 131.60M $1.12B -1.6%

表内 8 个季度中,机构持股合计减少 8%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+20.3%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 33.16M $254.34M 0.01% 增持
BlackRock Inc 19.97M $153.21M 0.00% 增持
SUMMER ROAD LLC 历史持仓 12.46M $95.59M 70.72% 增持
VANGUARD CAPITAL MANAGEMENT LLC 8.94M $68.58M 0.00% 增持
STATE STREET CORP 5.58M $42.76M 0.00% 增持
Geode Capital Management 5.27M $40.45M 0.00% 增持
DIMENSIONAL FUND ADVISORS LP 2.96M $22.72M 0.00% 增持
Marshall Wace 2.71M $20.76M 0.04% 增持
DELTEC ASSET MANAGEMENT LLC 历史持仓 2.62M $20.12M 3.17% 增持
UBS Group AG 2.13M $16.30M 0.01% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 1.95M $14.99M 0.00% 减持
Invesco Ltd 1.84M $14.15M 0.00% 增持
Nuveen, LLC 1.42M $10.92M 0.00% 减持
RAYMOND JAMES FINANCIAL INC 1.35M $10.33M 0.00% 增持
VANGUARD FIDUCIARY TRUST CO 1.35M $10.32M 0.00% 增持
Empire Life Investments Inc. 869.58K $6.67M 0.36% 持有
Cetera Investment Advisers 822.06K $6.31M 0.01% 增持
PEREGRINE CAPITAL MANAGEMENT LLC 765.78K $5.87M 0.20% 增持
Morgan Stanley 731.14K $5.61M 0.00% 减持
BNP PARIBAS FINANCIAL MARKETS 698.96K $5.36M 0.01% 增持
Aptus Capital Advisors, LLC 656.91K $5.04M 0.04% 增持
Second Line Capital, LLC 历史持仓 656.85K $5.04M 0.88% 增持
BNP Paribas Asset Management Holding S.A. 647.78K $4.97M 0.01% 增持
BNY Mellon 568.12K $4.36M 0.00% 增持
Renaissance Technologies 540.90K $4.15M 0.01% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 32.84M $322.53M 0.01% 增持
Deep Track Capital, LP 历史持仓 19.69M $193.32M 2.88% 持有
BlackRock Inc 19.38M $190.28M 0.00% 增持
Avoro Capital Advisors LLC 历史持仓 12.54M $123.14M 1.11% 增持
SUMMER ROAD LLC 历史持仓 12.21M $119.89M 74.46% 增持
Venrock Adviser, LLC 历史持仓 10.35M $101.61M 3.08% 持有
VANGUARD CAPITAL MANAGEMENT LLC 8.83M $86.74M 0.00% 增持
PRICE T ROWE ASSOCIATES INC /MD/ 7.62M $74.86M 0.01% 增持
Logos Global Management LP 历史持仓 5.30M $52.05M 2.24% 增持
GEODE CAPITAL MANAGEMENT, LLC 5.02M $49.32M 0.00% 新进
Geode Capital Management 5.02M $49.32M 0.00% 增持
Point72 Asset Management 3.29M $32.33M 0.13% 减持
DIMENSIONAL FUND ADVISORS LP 2.78M $27.33M 0.01% 增持
DELTEC ASSET MANAGEMENT LLC 历史持仓 2.48M $24.32M 4.15% 增持
Octagon Capital Advisors LP 历史持仓 2.08M $20.38M 1.83% 减持
VANGUARD PORTFOLIO MANAGEMENT LLC 1.97M $19.38M 0.00% 增持
Northern Trust Corp 1.80M $17.67M 0.00% 增持
Goldman Sachs Group 1.76M $17.30M 0.01% 增持
Nuveen, LLC 1.70M $16.67M 0.00% 增持
Woodline Partners LP 1.67M $16.38M 0.05% 持有
TCG Crossover Management, LLC 历史持仓 1.65M $16.18M 0.39% 持有
UBS Group AG 1.55M $15.23M 0.01% 增持
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.55M $15.22M 0.02% 新进
Charles Schwab Investment Management 1.53M $15.06M 0.00% 增持
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.53M $15.06M 0.00% 增持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 32.65M $276.58M 0.01% 增持
Deep Track Capital, LP 历史持仓 19.69M $166.74M 2.72% 增持
BlackRock Inc 16.13M $136.65M 0.00% 增持
Avoro Capital Advisors LLC 历史持仓 12.31M $104.31M 1.27% 增持
SUMMER ROAD LLC 历史持仓 11.88M $100.62M 70.84% 增持
Venrock Adviser, LLC 历史持仓 10.35M $87.64M 3.27% 增持
VANGUARD CAPITAL MANAGEMENT LLC 8.72M $73.85M 0.00% 新进
ALLIANCEBERNSTEIN L.P. 4.13M $50.13M 0.02% 减持
PRICE T ROWE ASSOCIATES INC /MD/ 5.90M $49.95M 0.01% 增持
Point72 Asset Management 5.53M $46.88M 0.19% 增持
STATE STREET CORP 4.71M $39.88M 0.00% 增持
Geode Capital Management 4.53M $38.37M 0.00% 增持
Logos Global Management LP 历史持仓 3.85M $32.61M 1.73% 增持
Octagon Capital Advisors LP 历史持仓 3.17M $26.82M 2.97% 增持
Balyasny Asset Management 2.69M $22.81M 0.08% 增持
Commodore Capital LP 2.58M $21.81M 1.26% 新进
DELTEC ASSET MANAGEMENT LLC 历史持仓 2.34M $19.83M 3.63% 减持
Two Sigma Investments 1.83M $15.50M 0.02% 增持
Woodline Partners LP 1.67M $14.12M 0.05% 持有
TCG Crossover Management, LLC 历史持仓 1.65M $13.96M 0.40% 减持
VANGUARD PORTFOLIO MANAGEMENT LLC 1.59M $13.51M 0.00% 新进
Invesco Ltd 1.54M $13.02M 0.00% 增持
Northern Trust Corp 1.53M $12.92M 0.00% 增持
UBS Group AG 1.52M $12.88M 0.01% 增持
Defilade Capital Management, L.P. 历史持仓 1.49M $12.60M 1.77% 增持

Q4 2025 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 31.79M $385.88M 0.02% 持有
BlackRock Inc 15.60M $189.41M 0.01% 增持
Vanguard Group 11.58M $140.52M 0.00% 增持
SUMMER ROAD LLC 历史持仓 11.11M $134.86M 97.92% 减持
Avoro Capital Advisors LLC 历史持仓 10.78M $130.84M 1.44% 增持
Deep Track Capital, LP 历史持仓 8.07M $97.97M 1.75% 减持
Venrock Adviser, LLC 历史持仓 7.32M $88.81M 4.39% 减持
TCG Crossover Management, LLC 历史持仓 5.74M $69.69M 2.31% 减持
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.63M $56.15M 0.09% 增持
Geode Capital Management 4.36M $52.90M 0.00% 增持
ALLIANCEBERNSTEIN L.P. 4.34M $52.71M 0.02% 增持
Janus Henderson Group 4.23M $51.32M 0.02% 增持
STATE STREET CORP 4.20M $50.94M 0.00% 增持
Logos Global Management LP 历史持仓 3.50M $42.49M 3.06% 增持
Millennium Management 3.28M $39.79M 0.02% 减持
Paradigm Biocapital Advisors LP 2.94M $35.63M 0.91% 减持
Octagon Capital Advisors LP 历史持仓 2.62M $31.85M 3.87% 持有
DELTEC ASSET MANAGEMENT LLC 历史持仓 2.49M $30.20M 5.00% 减持
Woodline Partners LP 1.67M $20.23M 0.08% 持有
Opaleye Management Inc. 历史持仓 1.59M $19.36M 2.56% 持有
Goldman Sachs Group 1.55M $18.79M 0.01% 增持
Saturn V Capital Management LP 1.50M $18.27M 3.35% 增持
Northern Trust Corp 1.46M $17.75M 0.00% 增持
Charles Schwab Investment Management 1.46M $17.73M 0.00% 增持
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.46M $17.73M 0.00% 增持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 31.79M $371.57M 0.02% 增持
Venrock Adviser, LLC 历史持仓 13.16M $153.86M 8.66% 增持
SUMMER ROAD LLC 历史持仓 12.58M $147.05M 98.57% 减持
Deep Track Capital, LP 历史持仓 11.93M $139.49M 3.89% 减持
BlackRock Inc 10.56M $123.41M 0.00% 持有
Avoro Capital Advisors LLC 历史持仓 10.25M $119.82M 1.78% 增持
Vanguard Group 9.16M $107.12M 0.00% 增持
TCG Crossover Management, LLC 历史持仓 6.12M $71.51M 3.52% 增持
Point72 Asset Management 4.60M $53.79M 0.21% 增持
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.00M $46.81M 0.07% 增持
MILLENNIUM MANAGEMENT LLC 3.86M $45.07M 0.07% 增持
Millennium Management 3.86M $45.07M 0.02% 增持
Paradigm Biocapital Advisors LP 3.50M $40.88M 1.36% 增持
STATE STREET CORP 3.46M $40.45M 0.00% 减持
ALLIANCEBERNSTEIN L.P. 3.42M $40.03M 0.01% 增持
Geode Capital Management 3.34M $39.03M 0.00% 增持
Logos Global Management LP 历史持仓 3.25M $37.99M 4.00% 增持
DELTEC ASSET MANAGEMENT LLC 历史持仓 2.76M $32.29M 5.33% 减持
Octagon Capital Advisors LP 历史持仓 2.62M $30.67M 4.79% 增持
Morgan Stanley 2.47M $28.82M 0.00% 减持
Balyasny Asset Management 2.19M $25.59M 0.09% 增持
Janus Henderson Group 2.05M $23.96M 0.01% 增持
Woodline Partners LP 1.67M $19.48M 0.09% 增持
Marshall Wace 1.60M $18.72M 0.03% 新进
Opaleye Management Inc. 历史持仓 1.59M $18.65M 2.64% 持有

Q2 2025 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 19.61M $181.96M 0.01% 增持
Deep Track Capital, LP 历史持仓 14.29M $132.65M 4.26% 持有
SUMMER ROAD LLC 历史持仓 13.89M $128.88M 98.23% 持有
Venrock Adviser, LLC 历史持仓 12.76M $118.44M 8.88% 持有
BlackRock Inc 10.55M $97.87M 0.00% 减持
Vanguard Group 8.39M $77.88M 0.00% 持有
Avoro Capital Advisors LLC 历史持仓 7.40M $68.67M 1.20% 减持
TCG Crossover Management, LLC 历史持仓 5.32M $49.36M 5.64% 持有
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.89M $36.10M 0.06% 减持
STATE STREET CORP 3.51M $32.56M 0.00% 增持
Paradigm Biocapital Advisors LP 3.42M $31.74M 1.35% 增持
Geode Capital Management 3.28M $30.48M 0.00% 减持
DELTEC ASSET MANAGEMENT LLC 历史持仓 2.79M $25.94M 4.62% 增持
Morgan Stanley 2.57M $23.87M 0.00% 增持
Octagon Capital Advisors LP 历史持仓 2.42M $22.50M 4.94% 持有
Logos Global Management LP 历史持仓 2.20M $20.42M 2.38% 减持
UBS Group AG 1.97M $18.24M 0.01% 增持
Point72 Asset Management 1.90M $17.67M 0.09% 减持
Opaleye Management Inc. 历史持仓 1.59M $14.80M 3.03% 持有
Invesco Ltd 1.54M $14.28M 0.00% 增持
Rosalind Advisors, Inc. 1.22M $11.31M 6.15% 持有
Franklin Resources 1.17M $10.86M 0.00% 持有
Northern Trust Corp 1.16M $10.73M 0.00% 减持
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.10M $10.17M 0.00% 减持
Charles Schwab Investment Management 1.10M $10.17M 0.00% 减持

查看全部 445 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Fidelity Management & Research (FMR) 33.16M 32.84M 32.65M 31.79M 31.79M 19.61M 941.29K 460.45K 434.37K 6.03K 69.09K 69.12K 68.78K 5.99K 4.75K 2.58K 5.04K 3.41K 2.14K —
BlackRock Inc 19.97M 19.38M 16.13M 15.60M 10.56M 10.55M 12.01M 11.85M 11.35M — — — — — — — — — — —
SUMMER ROAD LLC 12.46M 12.21M 11.88M 11.11M 12.58M 13.89M 13.88M 13.87M 14.40M 14.89M 14.36M 7.66M 6.12M — — — — — — —
VANGUARD CAPITAL MANAGEMENT LLC 8.94M 8.83M 8.72M — — — — — — — — — — — — — — — — —
STATE STREET CORP 5.58M — 4.71M 4.20M 3.46M 3.51M 3.39M 3.49M 3.48M 3.92M 2.40M 1.54M 1.78M — — — — — — —
Geode Capital Management 5.27M 5.02M 4.53M 4.36M 3.34M 3.28M 3.42M 3.24M 3.27M 3.45M 2.49M 1.74M 1.63M 1.57M 1.46M 1.41M 1.37M 1.35M 1.36M 1.32M
DIMENSIONAL FUND ADVISORS LP 2.96M 2.78M 649.76K — — — — — — — — 12.39K 12.39K — — — — — — —
Marshall Wace 2.71M 126.03K 740.80K 1.38M 1.60M — — — 87.74K 429.59K — — — 15.15K — — 531.64K — — —
DELTEC ASSET MANAGEMENT LLC 2.62M 2.48M 2.34M 2.49M 2.76M 2.79M 2.72M 2.62M 2.60M 2.59M 2.36M 2.44M 2.06M — — — — — — —
UBS Group AG 2.13M 1.55M 1.52M 1.24M 1.25M 1.97M 1.33M 876.55K 684.78K 748.73K 483.51K 90.83K 53.57K 129.95K 1.28K 1.28K 1.00K 342.23K 34.88K 94.89K
VANGUARD PORTFOLIO MANAGEMENT LLC 1.95M 1.97M 1.59M — — — — — — — — — — — — — — — — —
Invesco Ltd 1.84M 1.34M 1.54M 895.69K 1.04M 1.54M 804.83K 890.05K 755.47K 45.90K 772.37K 221.03K 249.94K 178.55K 169.15K 265.77K 135.99K 172.94K 160.32K 137.10K
Nuveen, LLC 1.42M 1.70M 411.08K 462.81K 345.36K 362.31K 414.10K — — — — — — — — — — — — —
RAYMOND JAMES FINANCIAL INC 1.35M 963.32K 859.49K 842.19K 1.01M 884.38K 364.24K 201.62K — — — — — — — — — — — —
VANGUARD FIDUCIARY TRUST CO 1.35M 1.29M 1.25M — — — — — — — — — — — — — — — — —
Empire Life Investments Inc. 869.58K 871.69K 884.30K 540.12K 251.26K — — — — — — — — — — — — — — —
Cetera Investment Advisers 822.06K 785.73K 764.62K 722.54K 714.07K 705.41K 721.36K 723.84K 719.50K 739.04K 725.99K 5.00K 610.10K — — — — — — —
PEREGRINE CAPITAL MANAGEMENT LLC 765.78K 753.50K 720.46K 571.10K 617.52K 861.96K 847.47K — — — — — — — — — — — — —
Morgan Stanley 731.14K 911.83K 1.28M 879.14K 2.47M 2.57M 2.19M 1.82M 1.58M 1.16M 1.37M 323.15K 246.43K 232.76K 1.18M 427.87K 188.31K 229.14K 221.66K 422.37K
BNP PARIBAS FINANCIAL MARKETS 698.96K 308.90K 75.15K 255.92K 29.50K 208.53K 54.48K 75.40K 35.80K 55.31K 185.31K 39.17K 70.86K — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold OCUL?

As of 2026-Q2, 271 institutional funds reported holding OCUL (OCULAR THERAPEUTIX INC) in SEC 13F filings, with a combined reported value of $2.05B.

How many shares of OCUL do institutions own?

13F filers reported 216.58M shares of OCUL, worth $2.05B in aggregate at the end of 2026-Q2.

Is institutional ownership of OCUL rising or falling?

Share counts moved +2.5% versus the prior quarter — accumulation.

Who are the top institutional holders of OCUL?

The largest 13F holders are Fidelity Management & Research (FMR), Deep Track Capital, LP, BlackRock Inc, Vanguard Group, Avoro Capital Advisors LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of OCULAR THERAPEUTIX INC?

The major shareholders of OCULAR THERAPEUTIX INC (OCUL) by reported 13F value are Fidelity Management & Research (FMR), Deep Track Capital, LP, BlackRock Inc, Vanguard Group, Avoro Capital Advisors LLC, among 445 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 OCUL」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/OCUL/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →